words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

Our Leadership Team

Co-Chief Executive Officer & Chief Financial Officer

JB - Cher Wee Pay

Pay Cher Wee serves as the Co-Chief Executive Officer & Chief Financial Officer (CFO) of Juniper Biologics, overseeing the global businesses, operations and financials of the organization.

Cher Wee is an accomplished strategy and finance executive with extensive leadership experience across various industries. He brings a wealth of expertise, accumulated over 30 years, in financial management, strategic planning, and operational excellence.

Cher Wee started his career as an auditor in Deloitte before embarking on his journey as a corporate executive in listed, privately held and government related organizations. Cher Wee served as the CFO at Venture Corporation Limited, Raffles Medical Group Ltd and Beyonics Pte Ltd. He also held leadership roles at Jurong Port Pte Ltd as its CFO and President of Business Units. He was the Chairman at Jurong Port Universal Terminal Pte Ltd, one of Asia Pacific’s largest independently operated tank terminals. He played key roles in growing the businesses, maintaining strong financial performances and pursuing operational excellence in these organizations.

An entrepreneur at heart, Cher Wee co-founded Accion Capital Management Pte Ltd, a Monetary Authority of Singapore registered fund management company. Prior to this, he served as Executive Vice President at GKG Investments Holdings, overseeing private and public investments in the Asia region.

Cher Wee graduated with a Bachelor in Accountancy degree from Nanyang Technological University. His commitment to giving back to the community is evident through his active involvement in local volunteer work, including serving on the Board of Directors for the Singapore Cancer Society from 2009 to 2015.

Co-CEO & Vice President and Regional General Manager of ANZ

maulik website

Maulik Shroff serves as Co-Chief Executive Officer & Vice President and General Manager for Juniper Biologics in Australia and New Zealand. He has more than 20 years experience in the pharmaceutical industry and has worked across geographies such as India, Australia and the Asia Pacific region.  

Maulik graduated with a Bachelors of Science in Bio Chemistry from India and also holds a Masters of Engineering in Information Technology from RMIT University in Melbourne Australia.

He started his pharmaceutical journey in India working for Emcure in sales and sales management roles. He continued his career in Australia working for Eli Lilly, Novartis and Mundipharma prior to joining Juniper Biologics. Over these years Maulik has successfully worked in various commercial and leadership roles. His leadership has spanned over different therapeutic areas including oncology.

 Maulik is passionate about building high performing teams to drive commercial innovation and improve patient outcomes.

Chief Commercial Officer

ben website

Benedict Ong is Chief Commercial Officer of Juniper Biologics overseeing its global marketing and commercial operations.

Prior to joining Juniper, Benedict has many years of commercial experiences in Pharmaceuticals, Next Generation Sequencing Diagnostics and Medical Devices focusing in the therapeutic area of oncology and haematology. He was holding to various local and regional sales and marketing positions in various established MNCs including Janssen and Roche.

Benedict graduated with a Bachelor in Pharmacy from National University of Singapore and is currently a registered pharmacist. He also holds a Master of Business Administration from the University of Birmingham.

Chief Human Resource Officer

JB-Joyce Ng

Joyce has over 13 years of Human Resource  experience; mainly as a HRBP/ generalist covering the full spectrum of HR functions. In the recent years, she undertakes a senior HR role leading a team across Asia with an AI-driven financial technology company.

She is familiar with the Asia-Pacific region having conducted senior searches throughout Asia and Oceania countries. Prior to her graduation, she also had experience in finance roles.

Joyce is effectively bi-lingual and has fluent English and Mandarin language skills. She graduated with a Bachelor in Business from University of London, the London School of Economics and Political Science, Post-graduate Diploma in HR and Talent Management from Singapore Human Resource Institute.

Vice President Communications and Corporate Affairs

stephVwebsite

Stephenie is an accomplished and experienced global corporate communications and marketing professional with a proven track record in b2b and b2c marketing and communications across multiple industries including broadcasting, financial services and insurance. She has more than 20 years of proven expertise in Brand and PR strategy, issues and crisis management, reputation management, internal and change communications as well as marketing and sponsorship activation.

Prior to Juniper Biologics, Stephenie was Chief Communications Officer at Mundipharma. She has also held key strategic communications roles within the financial services sector. These included serving as the Head of Communications at Barclays as well as the Director of Communications for Aviva Asia.

She also previously led the regional marketing communications function for ESPN Star Sports as Vice President, spearheading rebranding and corporate positioning strategies for the organization, as well as at Media Monitors where she advised clients from the Singapore government as well as Fortune 500 companies on the effectiveness of their communications strategies.

Stephenie holds a Master of Science in Organizational Communications and a Bachelor of Science in Mass Communications and Journalism from Southern Illinois University.

Head of Legal and Compliance

Rachel

Rachel is an experienced lawyer, qualified in England & Australia with over 25 years’ experience across different industries. In the last 15 years, she has been working in the healthcare industry with companies like Boston Scientific, Mundipharma and Lonza, providing robust legal and anti-corruption compliance advice and support in APAC, Latin America and Middle East. She has a broad international experience having lived and worked in 5 countries and has a wide-ranging cultural knowledge.

She is experienced in handling a broad spectrum of legal and compliance issues in business as well as different markets including M&As, market entry, litigation (US and ex-US), IP and commercial transactions.

Vice President and Regional General Manager of SEA

suresh website

Suresh Pragasam serve as Vice President and Regional General Manager of Juniper Biologics overseeing its South East Asia pharmaceutical operations.

Prior to Juniper, Suresh was Regional General Manager for Mundipharma and its operations in South East Asia, HongKong and Taiwan.

Before joining Mundipharma in March 2016, Suresh served as Strategic Development Director and Commercial Director for Sanofi Pharmaceuticals. In his role, he oversaw all aspects of the company’s strategic formulations and operations, Business Development and Commercial Operations for the company’s pharmaceutical business across Malaysia and Singapore. Suresh has previously held positions at UCB Pharma and GlaxoSmithKline Pharmaceuticals as the Commercial Director for Malaysia and Singapore, as well as various sales, marketing and commercial Excellence positions at GlaxoSmithKline Pharmaceuticals.

Suresh graduated with a Masters in Business Administration from Edith Cowan University, Australia.

Vice President and Regional General Manager of MEA

haytham website1

Haytham Ramzy serves as Vice President & General Manager, Middle-East & Africa for Juniper Biologics.

Haytham has over 16 years of pharmaceutical experience where he is most recently the Cluster Head in Egypt and Near East.  Haytham is a strategic and results-oriented leader with a successful track record in the pharmaceutical industry, partnering CEOs and Boards, leading stakeholder and employee engagement.

As Vice President & General Manager, MEA, Haytham will provide strategic direction to the region’s operations including all sales, marketing, reporting and compliance plans.  He will be responsible for establishing Juniper Biologics operations and building long-term partnerships with healthcare professionals, patient groups and government bodies.  He will be an important link between Juniper Biologics and channel partners in the MEA region, and will be accountable for all business development activities, with the aim of growing Juniper Biologics’ business portfolio.